ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Crosses Above 50 Day Moving Average – Here’s Why

Shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $12.34 and traded as high as $18.91. ChronoScale Corporation Common Stock shares last traded at $18.36, with a volume of 177,507 shares.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of ChronoScale Corporation Common Stock in a research report on Friday, March 27th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus price target of $6.00.

ChronoScale Corporation Common Stock Trading Up 0.4%

The company has a current ratio of 1.55, a quick ratio of 1.03 and a debt-to-equity ratio of 0.25. The company’s fifty day moving average is $12.34 and its 200-day moving average is $9.38. The firm has a market capitalization of $65.36 million, a P/E ratio of -3.41 and a beta of 0.86.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last posted its quarterly earnings data on Tuesday, April 28th. The company reported ($2.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($2.01). The firm had revenue of $2.14 million for the quarter, compared to the consensus estimate of $4.29 million. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%. As a group, sell-side analysts anticipate that ChronoScale Corporation Common Stock will post -0.1 earnings per share for the current fiscal year.

Institutional Trading of ChronoScale Corporation Common Stock

Hedge funds have recently bought and sold shares of the stock. Roble Belko & Company Inc lifted its holdings in shares of ChronoScale Corporation Common Stock by 104.5% during the 1st quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock worth $25,000 after acquiring an additional 1,195 shares during the period. Virtu Financial LLC bought a new position in shares of ChronoScale Corporation Common Stock during the 3rd quarter worth about $57,000. Shay Capital LLC bought a new position in shares of ChronoScale Corporation Common Stock during the 3rd quarter worth about $67,000. Geode Capital Management LLC lifted its holdings in shares of ChronoScale Corporation Common Stock by 68.9% during the 4th quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock worth $218,000 after acquiring an additional 10,281 shares during the period. Finally, Citadel Advisors LLC bought a new position in shares of ChronoScale Corporation Common Stock during the 3rd quarter worth about $198,000. 6.42% of the stock is owned by institutional investors.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.